Pharvaris NV
NASDAQ:PHVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharvaris NV
NASDAQ:PHVS
|
NL |
|
Dowlais Group Plc
F:6O7
|
UK |
|
Relmada Therapeutics Inc
F:4E2
|
US |
|
F
|
Fluor Corp
XBER:FLU
|
US |
|
M
|
Mondelez International Inc
DUS:KTF
|
US |
|
M
|
Morgan Stanley
F:DWD
|
US |
|
Nikon Corp
F:NKN
|
JP |
|
Brown-Forman Corp
F:BF5B
|
US |
|
P
|
Pliant Therapeutics Inc
F:9PT
|
US |
|
C
|
CVS Health Corp
XMUN:CVS
|
US |
|
A
|
Altria Group Inc
F:PHM7
|
US |
|
H
|
Humana Inc
F:HUM
|
US |
|
C
|
China Merchants Bank Co Ltd
XMUN:M4B
|
CN |
Intrinsic Value
The intrinsic value for
Pharvaris NV (PHVS) under the Base Case is hidden
USD.
Compared with the current market price of 34.42 USD, the stock appears hidden
.
Do our valuations actually work? See backtest results .
PHVS looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with PHVS’s past valuations and how the stock performed after similar periods.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Pharvaris NV.
The intrinsic value for
Pharvaris NV (PHVS) under the Base Case is hidden USD.
Compared with the current market price of 34.42 USD, the stock appears hidden.